ATARA BIOTHERAPEUTICS, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $32.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-16
- ATARA BIOTHERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $32.74M.
- ATARA BIOTHERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$85.31M.
- ATARA BIOTHERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$276.36M.
- ATARA BIOTHERAPEUTICS, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$228.40M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $32.74M 10-K · filed 2026-03-16 |
| 2024-12-31 | -$85.31M 10-K · filed 2026-03-16 |
| 2023-12-31 | -$276.36M 10-K · filed 2025-03-07 |
| 2022-12-31 | -$228.40M 10-K · filed 2024-03-28 |
| 2021-12-31 | -$340.30M 10-K · filed 2023-02-08 |
| 2020-12-31 | -$306.76M 10-K · filed 2023-02-08 |
| 2019-12-31 | -$291.05M 10-K · filed 2022-02-28 |
| 2018-12-31 | -$230.76M 10-K · filed 2021-03-01 |
| 2017-12-31 | -$12.89M 10-K · filed 2020-02-27 |
| 2016-12-31 | -$48.80M 10-K · filed 2019-02-26 |
| 2015-12-31 | -$57.23M 10-K · filed 2018-02-27 |
| 2014-12-31 | -$28.03M 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |